Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy. (Record no. 28970467)

MARC details
000 -LEADER
fixed length control field 02409 a2200697 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518003839.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201908s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1532-1827
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/s41416-018-0271-y
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Friedlander, Michael
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20190823
245 00 - TITLE STATEMENT
Title Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of cancer
Date of publication, distribution, etc. 10 2018
300 ## - PHYSICAL DESCRIPTION
Extent 1075-1085 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged, 80 and over
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element BRCA1 Protein
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element BRCA2 Protein
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Capsules
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cystadenocarcinoma, Serous
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease-Free Survival
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Maintenance Chemotherapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasm Recurrence, Local
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phthalazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platinum
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Young Adult
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matulonis, Ursula
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gourley, Charlie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name du Bois, Andreas
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vergote, Ignace
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rustin, Gordon
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Scott, Clare
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Meier, Werner
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shapira-Frommer, Ronnie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Safra, Tamar
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Matei, Daniela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shirinkin, Vadim
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Selle, Frédéric
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fielding, Anitra
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lowe, Elizabeth S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name McMurtry, Emma L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spencer, Stuart
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rowe, Philip
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mann, Helen
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parry, David
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ledermann, Jonathan
773 0# - HOST ITEM ENTRY
Title British journal of cancer
Related parts vol. 119
-- no. 9
-- p. 1075-1085
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/s41416-018-0271-y">https://doi.org/10.1038/s41416-018-0271-y</a>
Public note Available from publisher's website

No items available.